Beyond our interest in applying chemistry, biology, genetics and medicine to oncological issues, Nemucore's team has a higher, humanistic purpose of returning people to full health following a battle with cancer.  

For patients battling Acute Myeloid Leukemia that means undergoing chemotherapy, to kill all the leukemic cells, followed by a bone marrow/stem cell transplant to achieve a durable, disease free response.  

Unfortunately, most patients never make it through the chemotherapeutic treatment to proceed to the potentially curative transplant stage.

NMI-900, has been developed to improve killing of leukemic cells to increase the odds that a patient can go onto have a bone marrow/stem cell transplant to achieve a durable, disease free response.

At Nemucore we want to create more moments like this one shown in the attached video between AML survivor Bruce and his stem cell donor Mike.

By investing in Nemucore you can be part of the next generation of compelling, life saving moments.